Osaic Holdings’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Osaic Holdings’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.4K	Sell	450 -1,350	-75%	-$5.58K	﹤0.01%	7164
2025 Q4	$7.2K	Buy	+1,800	New	+$14.1K	﹤0.01%	6513
2025 Q3	–	Sell	-9	Closed	-$189	–	7909
2025 Q2	$189	Buy	+9	New	+$207	﹤0.01%	7511
2025 Q1	–	Sell	-9	Closed	-$293	–	7474
2024 Q4	$293	Hold	9	–	–	﹤0.01%	7125
2024 Q3	$372	Hold	9	–	–	﹤0.01%	7064
2024 Q2	$477	Buy	+9	New	+$426	﹤0.01%	6997
2022 Q1	–	Sell	-6	Closed	-$1K	–	7254
2021 Q4	$1K	Hold	6	–	–	﹤0.01%	7144
2021 Q3	$2K	Buy	+6	New	+$2.36K	﹤0.01%	6829
2021 Q2	–	Hold	0	–	–	–	6996
2021 Q1	–	Hold	0	–	–	–	6806
2020 Q4	–	Hold	0	–	–	–	6404
2020 Q3	–	Hold	0	–	–	–	6214
2020 Q2	–	Hold	0	–	–	–	6121
2020 Q1	–	Hold	0	–	–	–	6063

Other funds holding CANF

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Osaic Holdings's CANF Position: Q1 2026 in Review

Osaic Holdings reduced its Can-Fite BioPharma American Depositary Shares (CANF) stake by 75% in Q1 2026, selling an estimated $5.58K and leaving 450 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #7164.

Osaic Holdings first reported a position in CANF in Q3 2021 and has held it in 8 quarters since. The position peaked at $7.2K in Q4 2025. 14 funds tracked by Wall St. Rank hold CANF as of Q1 2026.

Osaic Holdings held 450 shares of Can-Fite BioPharma American Depositary Shares worth $1.4K as of Q1 2026.
Osaic Holdings sold 1,350 Can-Fite BioPharma American Depositary Shares shares in Q1 2026, an estimated $5.58K.
Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7164 holding.
Osaic Holdings first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2021 and has held it in 8 quarters since.
Osaic Holdings's Can-Fite BioPharma American Depositary Shares position peaked at $7.2K in Q4 2025.
14 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.